These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 23249166

  • 61. Soluble markers for diagnosis of malignant pleural mesothelioma.
    Cristaudo A, Bonotti A, Simonini S, Bruno R, Foddis R.
    Biomark Med; 2011 Apr; 5(2):261-73. PubMed ID: 21473730
    [Abstract] [Full Text] [Related]

  • 62. Diagnostic efficacy of electron microscopy and pleural effusion cytology for the distinction of pleural mesothelioma and lung adenocarcinoma.
    Domínguez-Malagón H, Cano-Valdez AM, González-Carrillo C, Campos-Salgado YE, Lara-Garcia A, Lopez-Mejia M, Corona-Cruz JF, Arrieta O.
    Ultrastruct Pathol; 2016 Apr; 40(5):254-60. PubMed ID: 27405014
    [Abstract] [Full Text] [Related]

  • 63. MESOMARK: a potential test for malignant pleural mesothelioma.
    Beyer HL, Geschwindt RD, Glover CL, Tran L, Hellstrom I, Hellstrom KE, Miller MC, Verch T, Allard WJ, Pass HI, Sardesai NY.
    Clin Chem; 2007 Apr; 53(4):666-72. PubMed ID: 17289801
    [Abstract] [Full Text] [Related]

  • 64. Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma.
    Bonotti A, Simonini S, Pantani E, Giusti L, Donadio E, Mazzoni MR, Chella A, Marconi L, Ambrosino N, Lucchi M, Mussi A, Cristaudo A, Foddis R.
    Int J Biol Markers; 2017 Mar 02; 32(1):e126-e131. PubMed ID: 27646775
    [Abstract] [Full Text] [Related]

  • 65. Does CA125 binding to mesothelin impact the detection of malignant mesothelioma?
    Creaney J, Dick IM, Dare H, Demelker Y, Nowak AK, Musk AW, Robinson BW.
    Lung Cancer; 2013 Apr 02; 80(1):39-44. PubMed ID: 23357461
    [Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
    Elia S, Massoud R, Guggino G, Cristino B, Cortese C, De Massimi AR, Zenobi R.
    Eur J Cardiothorac Surg; 2008 Apr 02; 33(4):723-7. PubMed ID: 18261916
    [Abstract] [Full Text] [Related]

  • 70. The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey.
    Paintal A, Raparia K, Zakowski MF, Nayar R.
    Cancer Cytopathol; 2013 Dec 02; 121(12):703-7. PubMed ID: 24039177
    [Abstract] [Full Text] [Related]

  • 71. Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report.
    Beije N, Kraan J, den Bakker MA, Maat APWM, van der Leest C, Cornelissen R, Van NM, Martens JWM, Aerts JGJV, Sleijfer S.
    Cell Oncol (Dordr); 2017 Oct 02; 40(5):511-519. PubMed ID: 28577209
    [Abstract] [Full Text] [Related]

  • 72. Soluble mesothelin-related Peptide and osteopontin as markers of response in malignant mesothelioma.
    Wheatley-Price P, Yang B, Patsios D, Patel D, Ma C, Xu W, Leighl N, Feld R, Cho BC, O'Sullivan B, Roberts H, Tsao MS, Tammemagi M, Anraku M, Chen Z, de Perrot M, Liu G.
    J Clin Oncol; 2010 Jul 10; 28(20):3316-22. PubMed ID: 20498407
    [Abstract] [Full Text] [Related]

  • 73. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
    Afify A, Lynne LC, Howell L.
    Diagn Cytopathol; 2007 Feb 10; 35(2):105-10. PubMed ID: 17230576
    [Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement.
    Saad RS, Lindner JL, Lin X, Liu YL, Silverman JF.
    Diagn Cytopathol; 2006 Dec 10; 34(12):801-6. PubMed ID: 17115439
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Diagnostic value of pleural fluid SMRP, CA125, MMP-7, and MMP-9 in malignant pleural effusion.
    Han G, Li J, Liu X, Guo R.
    Medicine (Baltimore); 2023 Jan 27; 102(4):e32759. PubMed ID: 36705352
    [Abstract] [Full Text] [Related]

  • 79. Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis.
    Cui A, Jin XG, Zhai K, Tong ZH, Shi HZ.
    BMJ Open; 2014 Feb 24; 4(2):e004145. PubMed ID: 24566531
    [Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.